Davis Selected Advisers Purchases 96,534 Shares of Cigna Group $CI

Davis Selected Advisers increased its position in Cigna Group (NYSE:CI) by 14.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 752,852 shares of the health services provider’s stock after purchasing an additional 96,534 shares during the quarter. Cigna Group makes up 0.9% of Davis Selected Advisers’ portfolio, making the stock its 27th largest holding. Davis Selected Advisers owned approximately 0.28% of Cigna Group worth $207,212,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC lifted its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after acquiring an additional 318 shares during the period. Sivia Capital Partners LLC lifted its holdings in shares of Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the period. NewEdge Advisors LLC lifted its holdings in shares of Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after acquiring an additional 958 shares during the period. Treasurer of the State of North Carolina lifted its holdings in shares of Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after acquiring an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. bought a new position in shares of Cigna Group during the second quarter valued at $163,000. 86.99% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Guggenheim reissued a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft lifted their price objective on Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a report on Tuesday, February 10th. Mizuho set a $330.00 price objective on Cigna Group in a report on Friday. Jefferies Financial Group cut their price objective on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a report on Monday, April 20th. Finally, UBS Group reissued a “buy” rating and set a $375.00 price objective on shares of Cigna Group in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $336.20.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Price Performance

Shares of CI stock opened at $283.14 on Friday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The firm’s 50 day moving average is $274.34 and its 200-day moving average is $276.94. The firm has a market capitalization of $74.62 billion, a price-to-earnings ratio of 12.77, a PEG ratio of 1.01 and a beta of 0.26. The company has a current ratio of 0.73, a quick ratio of 0.74 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the prior year, the business earned $6.74 earnings per share. Cigna Group’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts forecast that Cigna Group will post 30.35 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s dividend payout ratio is presently 28.13%.

Cigna Group News Roundup

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal?weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think?piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer?term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short?term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.